Cargando…
Galectin signatuares contribute to the heterogeneity of breast cancer and provide new prognostic information and therapeutic targets
Because of their ability to induce local immunosuppression and to confer cancer cells with resistance to apoptosis, members of the galectin family are emerging as a new class of actionable targets in cancer. Unfortunately, we have yet to obtain a clear picture of the galectin signatures in cancer ce...
Autores principales: | Grosset, Andrée-Anne, Labrie, Marilyne, Vladoiu, Maria Claudia, Yousef, Einas M, Gaboury, Louis, St-Pierre, Yves |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4951281/ https://www.ncbi.nlm.nih.gov/pubmed/26933916 http://dx.doi.org/10.18632/oncotarget.7784 |
Ejemplares similares
-
Expression and functions of galectin-7 in ovarian cancer
por: Labrie, Marilyne, et al.
Publicado: (2014) -
Cytosolic galectin-7 impairs p53 functions and induces chemoresistance in breast cancer cells
por: Grosset, Andrée-Anne, et al.
Publicado: (2014) -
A Mutation in the Carbohydrate Recognition Domain Drives a Phenotypic Switch in the Role of Galectin-7 in Prostate Cancer
por: Labrie, Marilyne, et al.
Publicado: (2015) -
The CCAAT/Enhancer-Binding Protein Beta-2 Isoform (CEBPβ-2) Upregulates Galectin-7 Expression in Human Breast Cancer Cells
por: Campion, Carole G., et al.
Publicado: (2014) -
Galectin-7 Expression Potentiates HER-2-Positive Phenotype in Breast Cancer
por: Grosset, Andrée-Anne, et al.
Publicado: (2016)